Loading insider details...
Latest Form 4 (Oct 1, 2026): Purchase of 30,000 XENE shares, $1.12M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Purchase | 30,000 | $1.12M |
| Mar 14, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 12,500 | n/a |
| Mar 11, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 75,000 | $630.0K |
| Jan 9, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 350,000 | n/a |
| Jan 2, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 40,000 | $299.6K |
| Dec 9, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 14,375 | $647.3K |
| Dec 3, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 97 | $4.4K |
| Oct 1, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 25,000 | $192.3K |
| Mar 13, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 275,000 | n/a |
| Jan 27, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 16,217 | $288.0K |